JP Morgan Chase
CDMO

JP Morgan Chase’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

JP Morgan Chase’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-142,191
Closed -$1.76M – 7867
2024
Q4 		$1.76M Buy
142,191
+33,507
+31% +$384K ﹤0.01% 4247
2024
Q3 		$1.24M Buy
108,684
+80,308
+283% +$806K ﹤0.01% 4335
2024
Q2 		$203K Buy
28,376
+2,373
+9% +$18.2K ﹤0.01% 5161
2024
Q1 		$174K Sell
26,003
-62,190
-71% -$428K ﹤0.01% 5414
2023
Q4 		$573K Buy
88,193
+10,538
+14% +$67.9K ﹤0.01% 4703
2023
Q3 		$733K Sell
77,655
-9,867
-11% -$119K ﹤0.01% 4276
2023
Q2 		$1.22M Buy
87,522
+9,365
+12% +$160K ﹤0.01% 3896
2023
Q1 		$1.47M Buy
78,157
+8,065
+12% +$132K ﹤0.01% 3769
2022
Q4 		$965K Buy
70,092
+13,159
+23% +$202K ﹤0.01% 4070
2022
Q3 		$1.09M Buy
56,933
+657
+1% +$12K ﹤0.01% 3929
2022
Q2 		$858K Buy
56,276
+10,292
+22% +$152K ﹤0.01% 4214
2022
Q1 		$936K Buy
45,984
+6,768
+17% +$138K ﹤0.01% 4320
2021
Q4 		$1.14M Sell
39,216
-86,794
-69% -$2.48M ﹤0.01% 4279
2021
Q3 		$2.72M Buy
126,010
+98,256
+354% +$2.37M ﹤0.01% 3523
2021
Q2 		$713K Sell
27,754
-204,526
-88% -$4.37M ﹤0.01% 4498
2021
Q1 		$4.23M Buy
232,280
+69,667
+43% +$1.16M ﹤0.01% 3108
2020
Q4 		$1.88M Buy
162,613
+137,313
+543% +$1.26M ﹤0.01% 3521
2020
Q3 		$195K Sell
25,300
-61,383
-71% -$465K ﹤0.01% 4373
2020
Q2 		$569K Sell
86,683
-66,535
-43% -$371K ﹤0.01% 3801
2020
Q1 		$783K Buy
153,218
+18,993
+14% +$115K ﹤0.01% 3565
2019
Q4 		$1.03M Buy
134,225
+40,467
+43% +$236K ﹤0.01% 3837
2019
Q3 		$497K Buy
93,758
+74,076
+376% +$460K ﹤0.01% 4181
2019
Q2 		$79K Sell
19,682
-109,519
-85% -$452K ﹤0.01% 5012
2019
Q1 		$549K Sell
129,201
-3,137
-2% -$12.8K ﹤0.01% 4155
2018
Q4 		$543K Buy
132,338
+116,313
+726% +$607K ﹤0.01% 4092
2018
Q3 		$110K Sell
16,025
-40,660
-72% -$241K ﹤0.01% 4914
2018
Q2 		$222K Sell
56,685
-40,433
-42% -$140K ﹤0.01% 4517
2018
Q1 		$284K Buy
97,118
+61,289
+171% +$189K ﹤0.01% 4239
2017
Q4 		$139K Sell
35,829
-36,240
-50% -$155K ﹤0.01% 4545
2017
Q3 		$224K Buy
72,069
+67,783
+1,581% +$255K ﹤0.01% 4081
2017
Q2 		$18K Hold
4,286
– – ﹤0.01% 4558
2017
Q1 		$20K Hold
4,286
– – ﹤0.01% 4713
2016
Q4 		$9K Sell
4,286
-135
-3% -$316 ﹤0.01% 4813
2016
Q3 		$13K Sell
4,421
-5
-0.1% -$13 ﹤0.01% 4265
2016
Q2 		$11K Buy
4,426
+140
+3% +$390 ﹤0.01% 4329
2016
Q1 		$13K Hold
4,286
– – ﹤0.01% 4193
2015
Q4 		$35K Hold
4,286
– – ﹤0.01% 3983
2015
Q3 		$31K Hold
4,286
– – ﹤0.01% 3818
2015
Q2 		$39K Hold
4,286
– – ﹤0.01% 3927
2015
Q1 		$41K Buy
+4,286
New +$41.3K ﹤0.01% 3951
2013
Q4 		– Sell
-2,697
Closed -$26K – 4269
2013
Q3 		$26K Sell
2,697
-14,871
-85% -$148K ﹤0.01% 4302
2013
Q2 		$159K Buy
+17,568
New +$184K ﹤0.01% 4052

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's CDMO Position: Q1 2025 in Review

JP Morgan Chase sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 142,191 shares — an estimated $1.76M sold.

JP Morgan Chase first reported a position in CDMO in Q2 2013 and held it in 42 quarters. The position peaked at $4.23M in Q1 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • JP Morgan Chase reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 142,191 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.76M.
  • JP Morgan Chase first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • JP Morgan Chase's Avid Bioservices, Inc. Common Stock position peaked at $4.23M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.